Light-assisted drying enables vaccine stabilization and supports cold-chain-independent distribution

1. W. H. Organization. State of the World’s Vaccines and Immunization (World Health Organization, 2009).

2. Pambudi, N. A., Sarifudin, A., Gandidi, I. M. & Romadhon, R. Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs. Energy Rep. 8, 955–972 (2022).

   Google Scholar 

3. Matthias, D. M., Robertson, J., Garrison, M. M., Newland, S. & Nelson, C. Freezing temperatures in the vaccine cold chain: A systematic literature review. Vaccine 25, 3980–3986 (2007).

   Google Scholar 

4. Boros, C. A., Hanlon, M., Gold, M. S. & Roberton, D. M. Storage at -3 c for 24 h alters the immunogenicity of pertussis vaccines. Vaccine 19, 3537–3542 (2001).

   Google Scholar 

5. Diminsky, D., Moav, N., Gorecki, M. & Barenholz, Y. Physical, chemical and immunological stability of cho-derived hepatitis b surface antigen (hbsag) particles. Vaccine 18, 3–17 (1999).

   Google Scholar 

6. Bolgiano, B. et al. Effect of physico-chemical modification on the immunogenicity of haemophilus influenzae type b oligosaccharide–crm197 conjugate vaccines. Vaccine 19, 3189–3200 (2001).

   Google Scholar 

7. Ho, M. M. et al. Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines. Vaccine 20, 3509–3522 (2002).

   Google Scholar 

8. Yakum, M. N., Ateudjieu, J., Walter, E. A. & Watcho, P. Vaccine storage and cold chain monitoring in the north west region of Cameroon: A cross sectional study. BMC Res. Notes 8, 145 (2015).

   Google Scholar 

9. Burgos, R. M. et al. The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution. DIC 10, 1–10 (2021).

   Google Scholar 

10. Nugrahanto, A. COVID-19 response efficacy with biofarma’s cold chain vaccine distribution system in Indonesia: An analysis of technology and policy synergy. Eduvest – J. Univ. Stud. 3, 1901–1914 (2023).

    Google Scholar 

11. Mutukuri, T. T., Wilson, N. E., Taylor, L. S., Topp, E. M. & Zhou, Q. T. Effects of drying method and excipient on the structure and physical stability of protein solids: Freeze drying vs. spray freeze drying. Int. J. Pharmaceut. 594, 120169 (2021).

    Google Scholar 

12. Tang, X. C. & Pikal, M. J. Design of freeze-drying processes for pharmaceuticals: Practical advice. Pharmaceut. Res. 21, 191–200 (2004).

    Google Scholar 

13. Vanbillemont, B., Carpenter, J. F., Probst, C. & Beer, T. D. The impact of formulation composition and process settings of traditional batch versus continuous freeze-drying on protein aggregation. J. Pharmaceut. Sci. 109, 3308–3318 (2020).

    Google Scholar 

14. Kasper, J. C. & Friess, W. The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur. J. Pharmaceut. Biopharmaceut. 78, 248–263 (2011).

    Google Scholar 

15. Kawasaki, H., Shimanouchi, T. & Kimura, Y. Recent development of optimization of lyophilization process. J. Chem. 2019, 9502856 (2019).

    Google Scholar 

16. Hassett, K. J. et al. Stabilization of a recombinant ricin toxin a subunit vaccine through lyophilization. Eur. J. Pharmaceut. Biopharmaceut. 85, 279–286 (2013).

    Google Scholar 

17. Hassett, K. J. et al. Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid a adjuvants. J. Pharmaceut. Sci. 104, 627–639 (2015).

    Google Scholar 

18. Naik, S. P. et al. Stability of heat stable, live attenuated rotavirus vaccine (Rotasiil®). Vaccine 35, 2962–2969 (2017).

    Google Scholar 

19. Bhatnagar, B. S., Bogner, R. H. & Pikal, M. J. Protein stability during freezing: Separation of stresses and mechanisms of protein stabilization. Pharmaceut. Dev. Technol. 12, 505–523 (2007).

    Google Scholar 

20. Arsiccio, A., McCarty, J., Pisano, R. & Shea, J.-E. Heightened cold-denaturation of proteins at the ice-water interface. J. Am. Chem. Soc. 142, 5722–5730 (2020).

    Google Scholar 

21. Rexroad, J., Wiethoff, C. M., Jones, L. S. & Middaugh, C. R. Lyophilization and the thermostability of vaccines. Cell Preserv. Technol. 1, 91–104 (2002).

    Google Scholar 

22. Crowe, J. H., Carpenter, J. F. & Crowe, L. M. The role of vitrification in anhydrobiosis. Annu. Rev. Physiol. 60, 73–103 (1998).

    Google Scholar 

23. Shin, W.-J. et al. Development of thermostable lyophilized sabin inactivated poliovirus vaccine. mBio 9, e02287–18 (2018).

24. Young, M. A., Antczak, A. T., Wawak, A., Elliott, G. D. & Trammell, S. R. Light-assisted drying for protein stabilization. J. Biomed. Opt. 23, 075007–075007 (2018).

    Google Scholar 

25. Young, M. A., Furr, D. P., McKeough, R. Q., Elliott, G. D. & Trammell, S. R. Light-assisted drying for anhydrous preservation of biological samples: optical characterization of the trehalose preservation matrix. Biomed. Opt. Exp. 11, 801–816 (2020).

    Google Scholar 

26. Tsegaye, A. A., Furr, D. P., Olson, G. & Trammell, S. R. Thermal stabilization of biologics inside glass vials using light-assisted drying (lad). Drying Technol. 42, 1591–1605 (2024).

    Google Scholar 

27. Anh Lam, P. et al. The application of light-assisted drying to the thermal stabilization of nucleic acid nanoparticles. Biopreserv. Biobank. 20, 451–460 (2022).

28. HogenEsch, H., O’Hagan, D. T. & Fox, C. B. Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want. npj Vaccines 3, 51 (2018).

29. Glenny, A., Pape, C., Waddington, H. & Wallace, W. The antigenic value of the toxin-antitoxin precipitate of Ramon. J. Pathol. Bacteriol. 29, 31–40 (1926).

    Google Scholar 

30. Thakkar, S. G., Ruwona, T. B., Williams, R. O. III. & Cui, Z. The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures. Hum. Vaccines Immunother. 13, 936–946 (2017).

    Google Scholar 

31. Clausi, A. L., Merkley, S. A., Carpenter, J. F. & Randolph, T. W. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying. J. Pharmaceut. Sci. 97, 2049–2061 (2008).

    Google Scholar 

32. Wolff, L., Flemming, J., Schmitz, R., Gröger, K. & Müller-Goymann, C. Protection of aluminum hydroxide during lyophilisation as an adjuvant for freeze-dried vaccines. Colloids Surf. A Physicochem. Eng. Asp. 330, 116–126 (2008).

    Google Scholar 

33. Devaux, C. A., Pontarotti, P., Levasseur, A., Colson, P. & Raoult, D. Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?. Front. Public Health 11, 1284337 (2024).

    Google Scholar 

34. Sutter, R. W., Eisenhawer, M., Molodecky, N. A., Verma, H. & Okayasu, H. Inactivated poliovirus vaccine: Recent developments and the tortuous path to global acceptance. Pathogens 13, 224 (2024).

    Google Scholar 

35. Thompson, K. M., Kalkowska, D. A., Kidd, S. E., Burns, C. C. & Badizadegan, K. Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization. Roush 152(42), 819–827 (2024).

    Google Scholar 

36. Furr, D. P. et al. Light-assisted drying (LAD): A new process for producing an amorphous trehalose preservation matrix for the storage of biologics. Eng. Rep. e12889 (2024).

37. Weyant, K. B. et al. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens. Nat. Commun. 14, 464 (2023).

    Google Scholar 

38. Kim, S.-H. et al. Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim. Biophys. Acta (BBA)-Biomembr. 1788, 2150–2159 (2009).

39. Champion, D., Le Meste, M. & Simatos, D. Towards an improved understanding of glass transition and relaxations in foods: Molecular mobility in the glass transition range. Trends Food Sci. Technol. 11, 41–55 (2000).

    Google Scholar 

40. Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M. & Rappuoli, R. The new multicomponent vaccine against meningococcal serogroup b, 4cmenb: Immunological, functional and structural characterization of the antigens. Vaccine 30, B87–B97 (2012).

    Google Scholar 

41. Carter, N. J. Multicomponent meningococcal serogroup b vaccine (4cmenb; Bexsero®): A review of its use in primary and booster vaccination. BioDrugs 27, 263–274 (2013).

    Google Scholar 

42. Tobin, G. J. et al. A highly immunogenic UVC inactivated sabin based polio vaccine. npj Vaccines 9, 217 (2024).

43. Haas, J. et al. In vivo assay guidelines. In Assay Guidance Manual [Internet] (2012).

44. Deghmane, A.-E. & Taha, M.-K. Product review on the IMD serogroup B vaccine Bexsero®. Hum. Vacc. Immunother. 18, 2020043 (2022).

    Google Scholar 

45. Lilliefors, H. W. On the Kolmogorov-Smirnov test for normality with mean and variance unknown. J. Am. Stat. Assoc. 62, 399–402 (1967).

    Google Scholar 

46. McDonald, J. H. Handbook of Biological Statistics (Sparky House Publishing, 2014).

    Google Scholar 

47. Welch, B. L. On the comparison of several mean values: An alternative approach. Biometrika 38, 330–336 (1951).

    Google Scholar 

48. Games, P. A. & Howell, J. F. Pairwise multiple comparison procedures with unequal n’s and/or variances: A Monte Carlo study. J. Educ. Stat. 1, 113–125 (1976).

    Google Scholar 

49. Kruskal, W. H. & Wallis, W. A. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583–621 (1952).

    Google Scholar 

50. Dunn, O. J. Multiple comparisons using rank sums. Technometrics 6, 241–252 (1964).

    Google Scholar 

51. Šidák, Z. Rectangular confidence regions for the means of multivariate normal distributions. J. Am. Stat. Assoc. 62, 626–633 (1967).

    Google Scholar 

Download references